Exhibit 10.27


 





AMENDMENT TO NOTE PURCHASE AGREEMENT


 


This Amendment to Note
Purchase Agreement (this “Amendment”) is entered into as of August 14, 2019 and effective as of August 12, 2019
(the “Effective Date”) by and between Chicago Venture Partners, L.P., a Utah limited partnership (“Investor”),
and Inpixon, a Nevada corporation (“Company”). Capitalized terms used in this Amendment without definition shall
have the meanings given to them in the Purchase Agreement (as defined below).


 


A.               
Company issued to Investor that certain Promissory Note dated June 27, 2019 in the original principal amount of $1,895,000.00
(the “Note”) pursuant to that certain Note Purchase Agreement by and between Company and Investor dated June
27, 2019 (the “Purchase Agreement”).


 


B.                
Investor and Company have agreed, subject to the terms, amendments, conditions and understandings expressed in this Amendment,
to amend the Purchase Agreement as set forth herein.


 


NOW, THEREFORE, for good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:


 


1.       Recitals.
Each of the parties hereto acknowledges and agrees that the recitals set forth above in this Amendment are true and accurate and
are hereby incorporated into and made a part of this Amendment.


 


2.       Amendment
to Section 4(iv) of the Purchase Agreement. As of the Effective Date, Company and Investor agree that the covenant set forth
in Section 4(iv) of the Purchase Agreement will not apply or be effective until December 27, 2019. The remaining terms and conditions
of the Purchase Agreement and the other Transaction Documents shall remain in full force and effect.


 


3.       Consideration
for Amendment. In consideration for the amendment set forth in Section 2 above, Investor’s fees incurred in preparing
this Amendment and the other accommodations set forth herein, Company hereby agrees that, as of the Effective Date, a fee in the
amount of $191,883.28 shall be added to the outstanding balance of the Note (the “Amendment Fee”). Following
the application of the Amendment Fee, each of Company and Investor acknowledges and agrees that the Outstanding Balance of the
Note is $2,111,249.13 as of the Effective Date. Investor and Company further agree that such Amendment Fee is deemed to be fully
earned as of the Effective Date and is nonrefundable under any circumstance.


 


4.       Representations
and Warranties. In order to induce Investor to enter into this Amendment, Company, for itself, and for its affiliates, successors
and assigns, hereby acknowledges, represents, warrants and agrees as follows:


 


(a)Company has
full power and authority to enter into this Amendment and to incur and perform all obligations and covenants contained herein,
all of which have been duly authorized by all proper and necessary action. No consent, approval, filing or registration with or
notice to any governmental authority is required as a condition to the validity of this Amendment or the performance of any of
the obligations of Company hereunder.



     


     

    




 


(b)There is no
fact known to Company or which should be known to Company which Company has not disclosed to Investor on or prior to the date of
this Amendment which would or could materially and adversely affect the understanding of Investor expressed in this Amendment or
any representation, warranty, or recital contained in this Amendment.


 


(c)Except as expressly
set forth in this Amendment, Company acknowledges and agrees that neither the execution and delivery of this Amendment nor any
of the terms, provisions, covenants, or agreements contained in this Amendment shall in any manner release, impair, lessen, modify,
waive, or otherwise affect the liability and obligations of Company under the terms of the Purchase Agreement.


 


(d)Company has
no defenses, affirmative or otherwise, rights of setoff, rights of recoupment, claims, counterclaims, actions or causes of action
of any kind or nature whatsoever against Investor, directly or indirectly, arising out of, based upon, or in any manner connected
with, the transactions contemplated hereby, whether known or unknown, which occurred, existed, was taken, permitted, or begun prior
to the execution of this Amendment and occurred, existed, was taken, permitted or begun in accordance with, pursuant to, or by
virtue of any of the terms or conditions of the Purchase Agreement. To the extent any such defenses, affirmative or otherwise,
rights of setoff, rights of recoupment, claims, counterclaims, actions or causes of action exist or existed, such defenses, rights,
claims, counterclaims, actions and causes of action are hereby waived, discharged and released. Company hereby acknowledges and
agrees that the execution of this Amendment by Investor shall not constitute an acknowledgment of or admission by Investor of the
existence of any claims or of liability for any matter or precedent upon which any claim or liability may be asserted.


 


(e)Company represents
and warrants that as of the date hereof no Events of Default or other material breaches exist under the Purchase Agreement, the
Note or any of the other Transaction Documents, or have occurred prior to the date hereof.


 


5.       Other
Terms Unchanged. The Purchase Agreement, as amended by this Amendment, the Note, and the other Transaction Documents remain
and continue in full force and effect, constitute legal, valid, and binding obligations of each of the parties, and are in all
respects agreed to, ratified, and confirmed. Any reference to any of the Purchase Agreement after the date of this Amendment is
deemed to be a reference to such Purchase Agreement as amended by this Amendment. If there is a conflict between the terms of this
Amendment and any Purchase Agreement, the terms of this Amendment shall control. No forbearance or waiver may be implied by this
Amendment. Company acknowledges that it is unconditionally obligated to pay the remaining balance of the Note and represents that
such obligation is not subject to any deductions, defenses, rights of offset, or counterclaims of any kind. Except as expressly
set forth herein, the execution, delivery, and performance of this Amendment shall not operate as a waiver of, or as an amendment
to, any right, power, or remedy of Investor under the Purchase Agreement, as in effect prior to the date hereof.


 


6.       No
Reliance. Company acknowledges and agrees that neither Investor nor any of its officers, directors, members, managers, equity
holders, representatives or agents has made any representations or warranties to Company or any of its agents, representatives,
officers, directors, or employees except as expressly set forth in this Amendment and the Purchase Agreement and, in making its
decision to enter into the transactions contemplated by this Amendment, Company is not relying on any representation, warranty,
covenant or promise of Investor or its officers, directors, members, managers, equity holders, agents or representatives other
than as set forth in this Amendment.


 


7.       Counterparts.
This Amendment may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together
shall constitute one instrument. The parties hereto confirm that any electronic copy of another party’s executed counterpart
of this Amendment (or such party’s signature page thereof) will be deemed to be an executed original thereof.


 


8.       Further
Assurances. Each party shall do and perform or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Amendment and the consummation of the transactions contemplated
hereby.


 


[Remainder of page intentionally left blank]









    2 


     

    

IN WITNESS WHEREOF, the undersigned have executed
this Amendment as of the date set forth above.


 


 


	 	 	COMPANY:
	 	 	 
	 	 	INPIXON
	 	 	 
	 	 	By:	/s/ Nadir Ali
	 	 	Name:	Nadir Ali
	 	 	Title:	CEO
	 	 	 
	 	 	INVESTOR:
	 	 	 
	 	 	CHICAGO VENTURE PARTNERS, L.P.
	 	 	 
	 	 	By: Chicago Venture
Management, L.L.C.,


its General Partner



	 	 	 
	 	 	By: CVM, Inc.,
its Manager
	 	 	 
	 	 	By:	/s/ John M. Fife
	 	 	John M. Fife, President









 









    3